secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRATED BIOPHARMA INC (INBP)
CIK:        0001016504
Form:       8-K
Filed at:   2026-04-15T23:59:59+00:00
Accession:  0001437749-26-012368
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 9.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Integrated BioPharma receives 3-month extension of PNC line of credit to July 14, 2026
--------------------------------------------------------------------------------

- PNC Bank notified Integrated BioPharma and subsidiary Manhattan Drug on April 14, 2026.
- Line of credit expiration extended from April 15, 2026 to July 14, 2026.
- Extension subject to PNC's sole discretion to designate a later date via written notice.
- No changes to other terms of the promissory note dated April 15, 2025 were disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1016504/000143774926012368/0001437749-26-012368-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1016504/000143774926012368/inbp20260415_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-012368

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer